Section Arrow
CGEM.NASDAQ
- Cullinan Therapeutics
Quotes are at least 15-min delayed:2024/12/24 12:56 EST
Last
 12.28
+0.41 (+3.45%)
Day High 
12.38 
Prev. Close
11.87 
1-M High
13.78 
Volume 
122.61K 
Bid
12.26
Ask
12.32
Day Low
11.675 
Open
11.87 
1-M Low
10.44 
Market Cap 
691.16M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 11.75 
20-SMA 12.32 
50-SMA 14.26 
52-W High 30.1886 
52-W Low 10 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.84/-2.80
Enterprise Value
693.31M
Balance Sheet
Book Value Per Share
10.78
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
TNXPTonix Pharmaceuticals Holding Corp.0.383529-0.019571-4.86%-- 
CMNDClearmind Medicine1.695+0.475+38.93%0.16PE
CEROCERo Therapeutics Holdings0.0603+0.0098+19.41%-- 
RXRXRecursion Pharmaceuticals7.2831+0.2931+4.19%-- 
CDTConduit Pharmaceuticals0.057699+0.003199+5.87%-- 
Quotes are at least 15-min delayed:2024/12/24 12:56 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Cullinan Therapeutics Inc is a biopharmaceutical company. It has diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, create differentiated ideas, identify the appropriate targets, and select the optimal modality to develop transformative therapeutics across a variety of cancerand autoimmune indications.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.